Evaluation of HDL functions in patients with sleep apnea syndrome

Evaluation of HDL functions in patients with sleep apnea syndrome - HDL functions in SAS patients

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000025335

Enrollment

140

Registered

2019-01-04

Start date

2017-04-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep apnea syndrome

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: AHI 15 or greater

Exclusion criteria

Exclusion criteria: 1) HbA1c >10% 2) recent cerebrovascular events (6 months) 3) liver dysfunction (AST/ALT greater than 3 fold of upper normal limits) 4) advanced renal inssuficiency including hemodialysis 5) heart failure (NYHA III/IV) 6) cancer or critically ill patients 7) pregnant women 8) serious infection 9) subjects to whom attending doctor judges inappropriate to join the study

Design outcomes

Primary

Measure	Time frame
HDL functions	—

Secondary

Measure	Time frame
lipids, apoproteins	—

Countries

Japan

Contacts

Public ContactKatsunori Ikewaki

National defense medical college Division of anti-aging, and vascular medicine

kikewaki@hotmail.com0429-95-1211

Outcome results